Dianthus Therapeutics Inc (DNTH) Profitability Comparisons, Net Margin, Gross Margin, Tax rate, Cash Flow Margin Comparisons - CSIMarket
CSIMarket Company Name, Ticker, Suppliers, else..
 


• Gross Margin
• EBITDA Margin
• Operating Margin
• Net Margin
• Pre-Tax Margin
• Effective Tax Rate
• Free Cash Flow Margin
• Cash Flow Margin
Dianthus Therapeutics Inc   (NASDAQ: DNTH)

Dianthus Therapeutics Inc Profitability Comparisons

Select each Category to receive further Information



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

DNTH Profitability Ratio

 Company Industry Sector S&P 500
Gross Profit Margin (Q2 MRQ) 0 % 76.79 % 71.76 % 58.89 %
Gross Margin (Q2 TTM) 47.19 % 74.58 % 68.12 % 51.79 %
Gross Profit Margin 5 Yr. Avg. - 67.81 % 65.55 % 48.95 %
EBITDA Margin (Q2 MRQ) 4.86 % 31.76 % 26.86 % 26.08 %
EBITDA Margin (Q2 TTM) -7014.16 % 30.64 % 24.74 % 22.74 %
EBITDA Margin 5 Yr. Avg. - 47.09 % 31.38 % 23.41 %
Operating Margin (Q2 MRQ) -8079.11 % 29.67 % 24.44 % 30.23 %
Operating Margin (Q2 TTM) -15117.56 % 26.95 % 21.16 % 22.52 %
Operating Margin 5 Yr. Avg. - 15.37 % 14.33 % 19.26 %
Pre-Tax Profit Margin (Q2 MRQ) 0 % 27.84 % 21.91 % 17.76 %
Pre-Tax Profit Margin (Q2 TTM) -7022.69 % 25.2 % 18.42 % 15.1 %
Pre-Tax Profit Margin 5 Yr. Avg. - 12.98 % 10.37 % 13.52 %
Net Margin (Q2 MRQ) -6598.55 % 23.04 % 18.03 % 14.44 %
Net Margin (Q2 TTM) -13341.15 % 20.63 % 14.93 % 12.18 %
Net Margin 5 Yr. Avg. - 5.79 % 6.08 % 10.8 %



Business Segment Profit Margin
 
License
  Explore License Segment  -